These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

730 related articles for article (PubMed ID: 29780391)

  • 1. Concepts Collide: Genomic, Immune, and Microbial Influences on the Tumor Microenvironment and Response to Cancer Therapy.
    Andrews MC; Reuben A; Gopalakrishnan V; Wargo JA
    Front Immunol; 2018; 9():946. PubMed ID: 29780391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The gut microbiome and cancer immunotherapeutics: A review of emerging data and implications for future gynecologic cancer research.
    McKenzie ND; Hong H; Ahmad S; Holloway RW
    Crit Rev Oncol Hematol; 2021 Jan; 157():103165. PubMed ID: 33227575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Could the menagerie of the gut microbiome really cure cancer? Hope or hype.
    Abid MB
    J Immunother Cancer; 2019 Apr; 7(1):92. PubMed ID: 30940203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring the Role of the Gut Microbiota in Modulating Colorectal Cancer Immunity.
    Shakhpazyan NK; Mikhaleva LM; Bedzhanyan AL; Gioeva ZV; Mikhalev AI; Midiber KY; Pechnikova VV; Biryukov AE
    Cells; 2024 Aug; 13(17):. PubMed ID: 39273009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of gut and intratumoral microbiota on the immune microenvironment and anti-cancer therapy.
    Chen Y; Liu B; Wei Y; Kuang DM
    Pharmacol Res; 2021 Dec; 174():105966. PubMed ID: 34728366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Impact of Intratumoral and Gastrointestinal Microbiota on Systemic Cancer Therapy.
    Cogdill AP; Gaudreau PO; Arora R; Gopalakrishnan V; Wargo JA
    Trends Immunol; 2018 Nov; 39(11):900-920. PubMed ID: 30392721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring immune responses in the tumor microenvironment.
    Wargo JA; Reddy SM; Reuben A; Sharma P
    Curr Opin Immunol; 2016 Aug; 41():23-31. PubMed ID: 27240055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring the Emerging Role of the Gut Microbiota and Tumor Microenvironment in Cancer Immunotherapy.
    Qiu Q; Lin Y; Ma Y; Li X; Liang J; Chen Z; Liu K; Huang Y; Luo H; Huang R; Luo L
    Front Immunol; 2020; 11():612202. PubMed ID: 33488618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An emerging strategy: probiotics enhance the effectiveness of tumor immunotherapy via mediating the gut microbiome.
    Jiang S; Ma W; Ma C; Zhang Z; Zhang W; Zhang J
    Gut Microbes; 2024; 16(1):2341717. PubMed ID: 38717360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The intratumoral microbiota: a new horizon in cancer immunology.
    Liu W; Li Y; Wu P; Guo X; Xu Y; Jin L; Zhao D
    Front Cell Infect Microbiol; 2024; 14():1409464. PubMed ID: 39135638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor and Host Factors Controlling Antitumor Immunity and Efficacy of Cancer Immunotherapy.
    Spranger S; Sivan A; Corrales L; Gajewski TF
    Adv Immunol; 2016; 130():75-93. PubMed ID: 26923000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The crosstalk between the gut microbiota and tumor immunity: Implications for cancer progression and treatment outcomes.
    Wang M; Zhang L; Chang W; Zhang Y
    Front Immunol; 2022; 13():1096551. PubMed ID: 36726985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut microbiome and adaptive immunity in schizophrenia.
    Agorastos A; Bozikas VP
    Psychiatriki; 2019; 30(3):189-192. PubMed ID: 31685450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Gut Microbiota in Causation, Detection, and Treatment of Cancer.
    Murphy CL; OʼToole PW; Shanahan F
    Am J Gastroenterol; 2019 Jul; 114(7):1036-1042. PubMed ID: 30848738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roles of microbiota in response to cancer immunotherapy.
    Inamura K
    Semin Cancer Biol; 2020 Oct; 65():164-175. PubMed ID: 31911189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Compartmentalization of the host microbiome: how tumor microbiota shapes checkpoint immunotherapy outcome and offers therapeutic prospects.
    Boesch M; Horvath L; Baty F; Pircher A; Wolf D; Spahn S; Straussman R; Tilg H; Brutsche MH
    J Immunother Cancer; 2022 Nov; 10(11):. PubMed ID: 36343977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Fusobacterium nucleatum with immunity and molecular alterations in colorectal cancer.
    Nosho K; Sukawa Y; Adachi Y; Ito M; Mitsuhashi K; Kurihara H; Kanno S; Yamamoto I; Ishigami K; Igarashi H; Maruyama R; Imai K; Yamamoto H; Shinomura Y
    World J Gastroenterol; 2016 Jan; 22(2):557-66. PubMed ID: 26811607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The microbiome, cancer, and cancer therapy.
    Helmink BA; Khan MAW; Hermann A; Gopalakrishnan V; Wargo JA
    Nat Med; 2019 Mar; 25(3):377-388. PubMed ID: 30842679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Host⁻MicroRNA⁻Microbiota Interactions in Colorectal Cancer.
    Yuan C; Steer CJ; Subramanian S
    Genes (Basel); 2019 Apr; 10(4):. PubMed ID: 30987065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut microbiota influence tumor development and Alter interactions with the human immune system.
    Ge Y; Wang X; Guo Y; Yan J; Abuduwaili A; Aximujiang K; Yan J; Wu M
    J Exp Clin Cancer Res; 2021 Jan; 40(1):42. PubMed ID: 33494784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.